Bliss GVS Pharma Limited has issued a postal ballot notice seeking shareholder approval for the appointment of two independent directors through a remote e-voting process. The pharmaceutical company published the notice in leading newspapers on April 10, 2026, in compliance with SEBI listing regulations.

Proposed Director Appointments

The company is seeking approval for two special resolutions related to director appointments:

E-Voting Process and Timeline

The postal ballot will be conducted exclusively through remote e-voting, with no physical ballot forms being distributed to shareholders. The company has engaged Central Depository Securities Limited (CDSL) to facilitate the electronic voting process.

Key Dates and Timeline

Shareholders whose names appear in the Register of Members or List of Beneficial Owners as of the cut-off date are eligible to participate in the voting process. Voting rights will be calculated based on the paid-up value of equity shares registered in shareholders' names as of April 7, 2026.

Regulatory Compliance and Documentation

The postal ballot notice has been prepared in accordance with Section 110 read with Section 108 of the Companies Act, 2013, and Rules 20 and 22 of the Companies (Management and Administration) Rules, 2014. The process also complies with MCA General Circular No. 14/2020 dated April 8, 2020, and subsequent circulars, including General Circular No. 03/2025 dated September 22, 2025.

The notice is available on multiple platforms for shareholder access:

• Company website: www.blissgvs.com • CDSL website: https://www.cdslindia.com/ • BSE website: https://www.bseindia.com/ • NSE website: https://www.nseindia.com/

Scrutinizer Appointment

The Board of Directors has appointed Mr. Vijay Yadav (Membership No. FCS 11990 and COP No. 16806), Partner of AVS & Associates, Practising Company Secretaries, as the Scrutinizer for conducting the postal ballot process. The scrutinizer will ensure fair and transparent conduct of the e-voting process, with their decision on ballot validity being final.

Shareholder Support and Assistance

Shareholders requiring assistance with the e-voting process can access support through multiple channels. The company has provided access to Frequently Asked Questions (FAQs) and an e-voting manual at www.evotingindia.com . Additionally, shareholders can contact the toll-free number 1800 21 09911 or reach out to Mr. Rakesh Dalvi, Senior Manager at CDSL, via helpdesk.evoting@cdslindia.com for technical support.

The results of the postal ballot will be communicated to stock exchanges where the company's equity shares are listed and will be displayed on both CDSL's website and the company's official website following the declaration.

Bliss GVS Pharma Limited has strengthened its board governance by appointing two seasoned professionals as Independent Directors and has now issued a postal ballot notice seeking shareholder approval. The pharmaceutical company announced through a board resolution dated April 03, 2026, that it has appointed Mr. Vijayanarayanan Mahadevan and Mr. Deepak Rameshchandra Shah as Non-Executive Independent Directors for five-year terms.

Postal Ballot Notice Details

The company issued a postal ballot notice on April 09, 2026, to both NSE and BSE for seeking member approval through remote e-voting process. The notice has been sent electronically to shareholders whose email addresses are registered with MUFG Intime India Private Limited (formerly Link Intime India Private Limited), the company's Registrar and Share Transfer Agent.

Board Resolution and Appointments

The Board of Directors, acting on the recommendation of the Nomination and Remuneration Committee, passed resolutions by circulation on April 03, 2026. Both appointments require special resolution approval from shareholders through the postal ballot process.

Profile of New Directors

Mr. Vijayanarayanan Mahadevan (DIN: 06639177)

Mr. Mahadevan brings extensive financial leadership experience spanning over 35 years across multiple organizations and geographies. As a Chartered Accountant, he has worked with prominent companies including Alcon, Sandoz, Novartis, and SHV Energy. His expertise encompasses establishing finance functions for new businesses across manufacturing, trading, and R&D environments, strategic financial leadership, and successfully turning around loss-making businesses into profitable operations.

Mr. Deepak Rameshchandra Shah (DIN: 06954206)

Mr. Shah is a Fellow Member of the Institute of Chartered Accountants of India (ICAI) with over 36 years of experience in taxation and audit. Based in Mumbai, he has held several key leadership positions including Former President of the Bombay Chartered Accountants' Society, Former Chairman of the Western Zone of AIFTP, and currently serves as Chairman of the Direct Taxation Committee of BCAS. He is also an Independent Director on boards of The Ruby Mills Limited, Marathon Nextgen Realty Limited, and Siyaram Silk Mills Limited.

Regulatory Compliance and Voting Process

Both directors have been confirmed as not being debarred from holding director positions by SEBI or any other regulatory authority. The appointments comply with SEBI regulations and related master circulars. The postal ballot notice is available on the company's website at www.blissgvs.com/postal-ballot and shareholders can vote through CDSL's remote e-voting platform.

The appointments will be effective for the full five-year term once shareholders provide their consent through the postal ballot process, with results to be declared on or before May 12, 2026.